Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Other financing activities (2020 - 2025)

Historic Other financing activities for Cellebrite DI (CLBT) over the last 6 years, with Q3 2025 value amounting to $553.1 million.

  • Cellebrite DI's Other financing activities rose 502838181.82% to $553.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $553.1 million, marking a year-over-year change of. This contributed to the annual value of $498.9 million for FY2024, which is 68764.02% up from last year.
  • Latest data reveals that Cellebrite DI reported Other financing activities of $553.1 million as of Q3 2025, which was up 502838181.82% from $533.8 million recorded in Q2 2025.
  • Cellebrite DI's Other financing activities' 5-year high stood at $553.1 million during Q3 2025, with a 5-year trough of -$156.3 million in Q3 2021.
  • For the 5-year period, Cellebrite DI's Other financing activities averaged around $18.7 million, with its median value being -$108.2 million (2023).
  • Its Other financing activities has fluctuated over the past 5 years, first plummeted by 54723.89% in 2021, then soared by 502838181.82% in 2025.
  • Quarter analysis of 5 years shows Cellebrite DI's Other financing activities stood at -$153.1 million in 2021, then grew by 17.93% to -$125.6 million in 2022, then grew by 24.25% to -$95.2 million in 2023, then surged by 99.99% to -$11000.0 in 2024, then skyrocketed by 5028381.82% to $553.1 million in 2025.
  • Its Other financing activities stands at $553.1 million for Q3 2025, versus $533.8 million for Q2 2025 and $510.2 million for Q1 2025.